How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question.

The FDA is expected to base its decision in part on the STELLAR clinical trial, which included 163 adult patients treated with subcutaneous sotatercept and 160 patients treated with a placebo.

Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 

The free webinar, scheduled for Sept. 29, will examine the benefits of using CCTA and FFR-CT to manage chest pain patients. 

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

The new ranking includes a total of 300 hospitals from around the globe. Did your facility make the cut? 

Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures. 

The mobile MRI from Siemens Healthineers is cleared for deployment and can be used from practically anywhere.

IR providers pay an average of $877,500 when settling such cases prior to a trial, while average jury awards total more than $2 million.